Visual hallucinations, white matter lesions and disease severity in Parkinson's disease
Identifieur interne : 003050 ( Main/Corpus ); précédent : 003049; suivant : 003051Visual hallucinations, white matter lesions and disease severity in Parkinson's disease
Auteurs : E. Kraft ; J. Winkelmann ; C. Trenkwalder ; D. P. AuerSource :
- Acta Neurologica Scandinavica [ 0001-6314 ] ; 1999-06.
English descriptors
Abstract
Objectives – To determine if visual hallucinations in patients with Parkinson's disease are associated with an increased prevalence of white matter lesions. Patients and methods – Fifteen patients with (group 1) and 15 patients without (group 2) a history of visual hallucinations were studied. Both groups were matched for age. Magnetic resonance imaging was performed in all patients using standard T2 weighted Fast‐Spin‐Echo sequences. Assessment of cerebral white matter changes was performed using a modification of established criteria, with semiquantitative evaluation of periventricular and deep white matter changes. Results – There was no significant group difference with regard to the total amount of white matter changes, nor was a group difference found between the amount or extent of periventricular hyperintensities or deep white matter lesions. Group 1 was significantly (P=0.001) more disabled as evaluated by Hoehn/Yahr stage controlling for age and duration of disease. Mean increases in Hoehn/Yahr stage were not significantly greater in group 1 compared with group 2 at a 2‐year follow‐up examination (0.6 vs 0.3, P=0.166). Conclusion – Our data suggest that visual hallucinations are an indicator of a more aggressive course of the disease, but are not associated with a higher prevalence of global or occipital white matter lesions.
Url:
DOI: 10.1111/j.1600-0404.1999.tb07365.x
Links to Exploration step
ISTEX:711D012843E8B012453FDD971B1D60AD82B91CDDLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Visual hallucinations, white matter lesions and disease severity in Parkinson's disease</title><author><name sortKey="Kraft, E" sort="Kraft, E" uniqKey="Kraft E" first="E." last="Kraft">E. Kraft</name><affiliation><mods:affiliation>Max Planck Institute of Psychiatry, Munich, Germany</mods:affiliation></affiliation><affiliation><mods:affiliation>Present address: Massachusetts General Hospital, NMR‐Center, Charlestown, USA</mods:affiliation></affiliation></author><author><name sortKey="Winkelmann, J" sort="Winkelmann, J" uniqKey="Winkelmann J" first="J." last="Winkelmann">J. Winkelmann</name><affiliation><mods:affiliation>Max Planck Institute of Psychiatry, Munich, Germany</mods:affiliation></affiliation></author><author><name sortKey="Trenkwalder, C" sort="Trenkwalder, C" uniqKey="Trenkwalder C" first="C." last="Trenkwalder">C. Trenkwalder</name><affiliation><mods:affiliation>Max Planck Institute of Psychiatry, Munich, Germany</mods:affiliation></affiliation></author><author><name sortKey="Auer, D P" sort="Auer, D P" uniqKey="Auer D" first="D. P." last="Auer">D. P. Auer</name><affiliation><mods:affiliation>Max Planck Institute of Psychiatry, Munich, Germany</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:711D012843E8B012453FDD971B1D60AD82B91CDD</idno><date when="1999" year="1999">1999</date><idno type="doi">10.1111/j.1600-0404.1999.tb07365.x</idno><idno type="url">https://api.istex.fr/document/711D012843E8B012453FDD971B1D60AD82B91CDD/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">003050</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Visual hallucinations, white matter lesions and disease severity in Parkinson's disease</title><author><name sortKey="Kraft, E" sort="Kraft, E" uniqKey="Kraft E" first="E." last="Kraft">E. Kraft</name><affiliation><mods:affiliation>Max Planck Institute of Psychiatry, Munich, Germany</mods:affiliation></affiliation><affiliation><mods:affiliation>Present address: Massachusetts General Hospital, NMR‐Center, Charlestown, USA</mods:affiliation></affiliation></author><author><name sortKey="Winkelmann, J" sort="Winkelmann, J" uniqKey="Winkelmann J" first="J." last="Winkelmann">J. Winkelmann</name><affiliation><mods:affiliation>Max Planck Institute of Psychiatry, Munich, Germany</mods:affiliation></affiliation></author><author><name sortKey="Trenkwalder, C" sort="Trenkwalder, C" uniqKey="Trenkwalder C" first="C." last="Trenkwalder">C. Trenkwalder</name><affiliation><mods:affiliation>Max Planck Institute of Psychiatry, Munich, Germany</mods:affiliation></affiliation></author><author><name sortKey="Auer, D P" sort="Auer, D P" uniqKey="Auer D" first="D. P." last="Auer">D. P. Auer</name><affiliation><mods:affiliation>Max Planck Institute of Psychiatry, Munich, Germany</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Acta Neurologica Scandinavica</title><idno type="ISSN">0001-6314</idno><idno type="eISSN">1600-0404</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1999-06">1999-06</date><biblScope unit="volume">99</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="362">362</biblScope><biblScope unit="page" to="367">367</biblScope></imprint><idno type="ISSN">0001-6314</idno></series><idno type="istex">711D012843E8B012453FDD971B1D60AD82B91CDD</idno><idno type="DOI">10.1111/j.1600-0404.1999.tb07365.x</idno><idno type="ArticleID">ANE362</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0001-6314</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>MRI: prognosis</term><term>Parkinson's disease</term><term>visual hallucinations</term><term>white matter lesions</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Objectives – To determine if visual hallucinations in patients with Parkinson's disease are associated with an increased prevalence of white matter lesions. Patients and methods – Fifteen patients with (group 1) and 15 patients without (group 2) a history of visual hallucinations were studied. Both groups were matched for age. Magnetic resonance imaging was performed in all patients using standard T2 weighted Fast‐Spin‐Echo sequences. Assessment of cerebral white matter changes was performed using a modification of established criteria, with semiquantitative evaluation of periventricular and deep white matter changes. Results – There was no significant group difference with regard to the total amount of white matter changes, nor was a group difference found between the amount or extent of periventricular hyperintensities or deep white matter lesions. Group 1 was significantly (P=0.001) more disabled as evaluated by Hoehn/Yahr stage controlling for age and duration of disease. Mean increases in Hoehn/Yahr stage were not significantly greater in group 1 compared with group 2 at a 2‐year follow‐up examination (0.6 vs 0.3, P=0.166). Conclusion – Our data suggest that visual hallucinations are an indicator of a more aggressive course of the disease, but are not associated with a higher prevalence of global or occipital white matter lesions.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>E. Kraft</name><affiliations><json:string>Max Planck Institute of Psychiatry, Munich, Germany</json:string><json:string>Present address: Massachusetts General Hospital, NMR‐Center, Charlestown, USA</json:string></affiliations></json:item><json:item><name>J. Winkelmann</name><affiliations><json:string>Max Planck Institute of Psychiatry, Munich, Germany</json:string></affiliations></json:item><json:item><name>C. Trenkwalder</name><affiliations><json:string>Max Planck Institute of Psychiatry, Munich, Germany</json:string></affiliations></json:item><json:item><name>D. P. Auer</name><affiliations><json:string>Max Planck Institute of Psychiatry, Munich, Germany</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>visual hallucinations</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>white matter lesions</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>MRI: prognosis</value></json:item></subject><articleId><json:string>ANE362</json:string></articleId><language><json:string>eng</json:string></language><abstract>Objectives – To determine if visual hallucinations in patients with Parkinson's disease are associated with an increased prevalence of white matter lesions. Patients and methods – Fifteen patients with (group 1) and 15 patients without (group 2) a history of visual hallucinations were studied. Both groups were matched for age. Magnetic resonance imaging was performed in all patients using standard T2 weighted Fast‐Spin‐Echo sequences. Assessment of cerebral white matter changes was performed using a modification of established criteria, with semiquantitative evaluation of periventricular and deep white matter changes. Results – There was no significant group difference with regard to the total amount of white matter changes, nor was a group difference found between the amount or extent of periventricular hyperintensities or deep white matter lesions. Group 1 was significantly (P=0.001) more disabled as evaluated by Hoehn/Yahr stage controlling for age and duration of disease. Mean increases in Hoehn/Yahr stage were not significantly greater in group 1 compared with group 2 at a 2‐year follow‐up examination (0.6 vs 0.3, P=0.166). Conclusion – Our data suggest that visual hallucinations are an indicator of a more aggressive course of the disease, but are not associated with a higher prevalence of global or occipital white matter lesions.</abstract><qualityIndicators><score>5.886</score><pdfVersion>1.4</pdfVersion><pdfPageSize>576 x 791.759 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>4</keywordCount><abstractCharCount>1357</abstractCharCount><pdfWordCount>2950</pdfWordCount><pdfCharCount>20030</pdfCharCount><pdfPageCount>6</pdfPageCount><abstractWordCount>203</abstractWordCount></qualityIndicators><title>Visual hallucinations, white matter lesions and disease severity in Parkinson's disease</title><genre><json:string>article</json:string></genre><host><volume>99</volume><publisherId><json:string>ANE</json:string></publisherId><pages><total>6</total><last>367</last><first>362</first></pages><issn><json:string>0001-6314</json:string></issn><issue>6</issue><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1600-0404</json:string></eissn><title>Acta Neurologica Scandinavica</title><doi><json:string>10.1111/(ISSN)1600-0404</json:string></doi></host><publicationDate>1999</publicationDate><copyrightDate>1999</copyrightDate><doi><json:string>10.1111/j.1600-0404.1999.tb07365.x</json:string></doi><id>711D012843E8B012453FDD971B1D60AD82B91CDD</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/711D012843E8B012453FDD971B1D60AD82B91CDD/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/711D012843E8B012453FDD971B1D60AD82B91CDD/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/711D012843E8B012453FDD971B1D60AD82B91CDD/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Visual hallucinations, white matter lesions and disease severity in Parkinson's disease</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><availability><p>WILEY</p></availability><date>1999</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Visual hallucinations, white matter lesions and disease severity in Parkinson's disease</title><author><persName><forename type="first">E.</forename><surname>Kraft</surname></persName><affiliation>Max Planck Institute of Psychiatry, Munich, Germany</affiliation><affiliation>Present address: Massachusetts General Hospital, NMR‐Center, Charlestown, USA</affiliation></author><author><persName><forename type="first">J.</forename><surname>Winkelmann</surname></persName><affiliation>Max Planck Institute of Psychiatry, Munich, Germany</affiliation></author><author><persName><forename type="first">C.</forename><surname>Trenkwalder</surname></persName><affiliation>Max Planck Institute of Psychiatry, Munich, Germany</affiliation></author><author><persName><forename type="first">D. P.</forename><surname>Auer</surname></persName><note type="correspondence"><p>Correspondence: Max Planck Institute of Psychiatry, Kraepelinstraße 10, 80804 Munich, Germany</p></note><affiliation>Max Planck Institute of Psychiatry, Munich, Germany</affiliation></author></analytic><monogr><title level="j">Acta Neurologica Scandinavica</title><idno type="pISSN">0001-6314</idno><idno type="eISSN">1600-0404</idno><idno type="DOI">10.1111/(ISSN)1600-0404</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1999-06"></date><biblScope unit="volume">99</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="362">362</biblScope><biblScope unit="page" to="367">367</biblScope></imprint></monogr><idno type="istex">711D012843E8B012453FDD971B1D60AD82B91CDD</idno><idno type="DOI">10.1111/j.1600-0404.1999.tb07365.x</idno><idno type="ArticleID">ANE362</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1999</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Objectives – To determine if visual hallucinations in patients with Parkinson's disease are associated with an increased prevalence of white matter lesions. Patients and methods – Fifteen patients with (group 1) and 15 patients without (group 2) a history of visual hallucinations were studied. Both groups were matched for age. Magnetic resonance imaging was performed in all patients using standard T2 weighted Fast‐Spin‐Echo sequences. Assessment of cerebral white matter changes was performed using a modification of established criteria, with semiquantitative evaluation of periventricular and deep white matter changes. Results – There was no significant group difference with regard to the total amount of white matter changes, nor was a group difference found between the amount or extent of periventricular hyperintensities or deep white matter lesions. Group 1 was significantly (P=0.001) more disabled as evaluated by Hoehn/Yahr stage controlling for age and duration of disease. Mean increases in Hoehn/Yahr stage were not significantly greater in group 1 compared with group 2 at a 2‐year follow‐up examination (0.6 vs 0.3, P=0.166). Conclusion – Our data suggest that visual hallucinations are an indicator of a more aggressive course of the disease, but are not associated with a higher prevalence of global or occipital white matter lesions.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Parkinson's disease</term></item><item><term>visual hallucinations</term></item><item><term>white matter lesions</term></item><item><term>MRI: prognosis</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1999-06">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/711D012843E8B012453FDD971B1D60AD82B91CDD/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Publishing Ltd</publisherName><publisherLoc>Oxford, UK</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1600-0404</doi><issn type="print">0001-6314</issn><issn type="electronic">1600-0404</issn><idGroup><id type="product" value="ANE"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="ACTA NEUROLOGICA SCANDINAVICA">Acta Neurologica Scandinavica</title></titleGroup></publicationMeta><publicationMeta level="part" position="06006"><doi origin="wiley">10.1111/ane.1999.99.issue-6</doi><numberingGroup><numbering type="journalVolume" number="99">99</numbering><numbering type="journalIssue" number="6">6</numbering></numberingGroup><coverDate startDate="1999-06">June 1999</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="6" status="forIssue"><doi origin="wiley">10.1111/j.1600-0404.1999.tb07365.x</doi><idGroup><id type="unit" value="ANE362"></id></idGroup><countGroup><count type="pageTotal" number="6"></count></countGroup><titleGroup><title type="tocHeading1">Original Articles</title></titleGroup><copyright>Copyright © 1999 Munksgaard</copyright><eventGroup><event type="firstOnline" date="2009-01-29"></event><event type="publishedOnlineFinalForm" date="2009-01-29"></event><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.6 mode:FullText source:HeaderRef result:HeaderRef" date="2010-04-20"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:4.0.1" date="2014-03-15"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-14"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="362">362</numbering><numbering type="pageLast" number="367">367</numbering></numberingGroup><correspondenceTo>Max Planck Institute of Psychiatry, Kraepelinstraße 10, 80804 Munich, Germany</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:ANE.ANE362.pdf"></link></linkGroup></publicationMeta><contentMeta><unparsedEditorialHistory>Accepted for publication January 12, 1999</unparsedEditorialHistory><countGroup><count type="referenceTotal" number="27"></count><count type="linksCrossRef" number="6"></count></countGroup><titleGroup><title type="main">Visual hallucinations, white matter lesions and disease severity in Parkinson's disease</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1 #a2"><personName><givenNames>E.</givenNames><familyName>Kraft</familyName></personName></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#a1"><personName><givenNames>J.</givenNames><familyName>Winkelmann</familyName></personName></creator><creator creatorRole="author" xml:id="cr3" affiliationRef="#a1"><personName><givenNames>C.</givenNames><familyName>Trenkwalder</familyName></personName></creator><creator creatorRole="author" xml:id="cr4" affiliationRef="#a1" corresponding="yes"><personName><givenNames>D. P.</givenNames><familyName>Auer</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="a1" countryCode="DE"><unparsedAffiliation>Max Planck Institute of Psychiatry, Munich, Germany</unparsedAffiliation></affiliation><affiliation xml:id="a2" countryCode="US"><unparsedAffiliation>Present address: Massachusetts General Hospital, NMR‐Center, Charlestown, USA</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en"><keyword xml:id="k1">Parkinson's disease</keyword><keyword xml:id="k2">visual hallucinations</keyword><keyword xml:id="k3">white matter lesions</keyword><keyword xml:id="k4">MRI: prognosis</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><p><i>Objectives</i> – To determine if visual hallucinations in patients with Parkinson's disease are associated with an increased prevalence of white matter lesions. <i>Patients and methods</i> – Fifteen patients with (group 1) and 15 patients without (group 2) a history of visual hallucinations were studied. Both groups were matched for age. Magnetic resonance imaging was performed in all patients using standard T<sub>2</sub> weighted Fast‐Spin‐Echo sequences. Assessment of cerebral white matter changes was performed using a modification of established criteria, with semiquantitative evaluation of periventricular and deep white matter changes. <i>Results</i> – There was no significant group difference with regard to the total amount of white matter changes, nor was a group difference found between the amount or extent of periventricular hyperintensities or deep white matter lesions. Group 1 was significantly (<i>P</i>=0.001) more disabled as evaluated by Hoehn/Yahr stage controlling for age and duration of disease. Mean increases in Hoehn/Yahr stage were not significantly greater in group 1 compared with group 2 at a 2‐year follow‐up examination (0.6 vs 0.3, <i>P</i>=0.166). <i>Conclusion</i> – Our data suggest that visual hallucinations are an indicator of a more aggressive course of the disease, but are not associated with a higher prevalence of global or occipital white matter lesions.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Visual hallucinations, white matter lesions and disease severity in Parkinson's disease</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Visual hallucinations, white matter lesions and disease severity in Parkinson's disease</title></titleInfo><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Kraft</namePart><affiliation>Max Planck Institute of Psychiatry, Munich, Germany</affiliation><affiliation>Present address: Massachusetts General Hospital, NMR‐Center, Charlestown, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Winkelmann</namePart><affiliation>Max Planck Institute of Psychiatry, Munich, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Trenkwalder</namePart><affiliation>Max Planck Institute of Psychiatry, Munich, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D. P.</namePart><namePart type="family">Auer</namePart><affiliation>Max Planck Institute of Psychiatry, Munich, Germany</affiliation><description>Correspondence: Max Planck Institute of Psychiatry, Kraepelinstraße 10, 80804 Munich, Germany</description><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><place><placeTerm type="text">Oxford, UK</placeTerm></place><dateIssued encoding="w3cdtf">1999-06</dateIssued><edition>Accepted for publication January 12, 1999</edition><copyrightDate encoding="w3cdtf">1999</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="references">27</extent></physicalDescription><abstract lang="en">Objectives – To determine if visual hallucinations in patients with Parkinson's disease are associated with an increased prevalence of white matter lesions. Patients and methods – Fifteen patients with (group 1) and 15 patients without (group 2) a history of visual hallucinations were studied. Both groups were matched for age. Magnetic resonance imaging was performed in all patients using standard T2 weighted Fast‐Spin‐Echo sequences. Assessment of cerebral white matter changes was performed using a modification of established criteria, with semiquantitative evaluation of periventricular and deep white matter changes. Results – There was no significant group difference with regard to the total amount of white matter changes, nor was a group difference found between the amount or extent of periventricular hyperintensities or deep white matter lesions. Group 1 was significantly (P=0.001) more disabled as evaluated by Hoehn/Yahr stage controlling for age and duration of disease. Mean increases in Hoehn/Yahr stage were not significantly greater in group 1 compared with group 2 at a 2‐year follow‐up examination (0.6 vs 0.3, P=0.166). Conclusion – Our data suggest that visual hallucinations are an indicator of a more aggressive course of the disease, but are not associated with a higher prevalence of global or occipital white matter lesions.</abstract><subject lang="en"><genre>Keywords</genre><topic>Parkinson's disease</topic><topic>visual hallucinations</topic><topic>white matter lesions</topic><topic>MRI: prognosis</topic></subject><relatedItem type="host"><titleInfo><title>Acta Neurologica Scandinavica</title></titleInfo><genre type="Journal">journal</genre><identifier type="ISSN">0001-6314</identifier><identifier type="eISSN">1600-0404</identifier><identifier type="DOI">10.1111/(ISSN)1600-0404</identifier><identifier type="PublisherID">ANE</identifier><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>99</number></detail><detail type="issue"><caption>no.</caption><number>6</number></detail><extent unit="pages"><start>362</start><end>367</end><total>6</total></extent></part></relatedItem><identifier type="istex">711D012843E8B012453FDD971B1D60AD82B91CDD</identifier><identifier type="DOI">10.1111/j.1600-0404.1999.tb07365.x</identifier><identifier type="ArticleID">ANE362</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 1999 Munksgaard</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Blackwell Publishing Ltd</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003050 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 003050 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:711D012843E8B012453FDD971B1D60AD82B91CDD
|texte= Visual hallucinations, white matter lesions and disease severity in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |